Last updated on July 2017

Drug Use Surveillance of Takecab for "Gastric Ulcer Duodenal Ulcer and Reflux Esophagitis"


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of vonoprazan tablets (Takecab tablets) in patients with gastric ulcer, duodenal ulcer, and reflux esophagitis in the routine clinical setting.

Detailed Study Description

The drug being tested in this study is called Vonoprazan (Takecab). Vonoprazan is being tested to treat people who have gastric ulcer, duodenal ulcer, and reflux esophagitis. This study will look at the safety and efficacy of Vonoprazan in patients with gastric ulcer, duodenal ulcer, and reflux esophagitis in the routine clinical setting. The study will enroll approximately 3000 patients. • Vonoprazan 20 mg This multi-center trial will be conducted in Japan.

Clinical Study Identifier: NCT03214952

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Takeda Study Registration Call Center

Takeda Selected Site
Tokyo, Japan
  Connect »